BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation

Author(s): Hu Y, Russek S

Abstract

It is clear that brain-derived neurotrophic factor (BDNF) plays a crucial role in organizing the response of the genome to dynamic changes in the extracellular environment that enable brain plasticity. BDNF has emerged as one of the most important signaling molecules for the developing nervous system as well as the impaired nervous system, and multiple diseases, such as Alzheimer’s, Parkinson’s, Huntington’s, epilepsy, Rett’s syndrome, and psychiatric depression, are linked by their association with potential dysregulation of BDNF-driven signal transduction programs. These programs are responsible for controlling the amount of activated transcription factors, such as cAMP response element binding protein, that coordinate the expression of multiple brain proteins, like ion channels and early growth response factors, whose job is to maintain the balance of excitation and inhibition in the nervous system. In this review, we will explore the evidence for BDNF's role in gene regulation side by side with its potential role in the etiology of neurological diseases. It is hoped that by bringing the datasets together in these diverse fields we can help develop the foundation for future studies aimed at understanding basic principles of gene regulation in the nervous system and how they can be harnessed to develop new therapeutic opportunities.

Similar Articles

The non-cognitive features of dementia

Author(s): Allen NHP, Burns A

Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Author(s): Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Engchild J, et al.

Protein folding assisted by chaperones

Author(s): Borges JC, Ramos CH

Heat shock protein 70 in Alzheimer's disease

Author(s): Lu RC, Tan MS, Wang H, Xie AM, Yu JT, et al.

BDNF is essential to promote persistence of long-term memory storage

Author(s): Bekinstein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, et al.

BDNF in sleep, insomnia, and sleep deprivation

Author(s): Schmitt K, Holsboer-Trachler E, EC-Kert A

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease

Author(s): Philips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, et al.

The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients

Author(s): Ciaramella A, Salani F, Bizzoni F, Orfei MD, Langella Rangelucci F, et al.

Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?

Author(s): Fahnestock M, Garzon D, Holsinger RM, Michalski B

BDNF and full-length and truncated TrkB expression in Alzheimer disease

Author(s): Ferreer I, Marin C, Rey MJ, Ribalta T, Goutane, et al.

The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease

Author(s): Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, et al.

Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease

Author(s): Nacmias B, Tedde A, Forleo P, Piacentini S, Guamieri BM, et al.